Plenge Robert M
SEC CIK 1773367 · EDGAR
BoughtSold
Most active insiders at BMRN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davis George Eric | EVP, CLO | — | $2.76M |
| 2 | Guyer Charles Greg | EVP, Chief Technical Off | — | $996.7K |
| 3 | Friberg Gregory R | EVP, Chief R, D Off | — | $558.6K |
| 4 | Ramchandani Rashmi Virendra | VP, CAO | — | — |
| 5 | Hubbard Cristin | EVP, Chief Commercial Off | — | — |
| 6 | Hardy Alexander | CEO, Dir | — | — |
| 7 | Plenge Robert M | Dir | — | — |
| 8 | ANDERSON ELIZABETH M | Dir | — | — |
| 9 | Bodem Barbara W. | Dir | — | — |
| 10 | Ho Maykin | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 18:55 | 2026-09-10 | BMRN | BIOMARIN PHARMACEUTICAL INC | Plenge Robert M | Dir | A - Grant | $0.00 | +6,140 | 6,140 | New | $0 | |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | F - Tax | $60.13 | -4,535 | 16.4K | -22% | -$272.7K |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | J - Other | $0.00 | -7,277 | 16.8K | -30% | $0 |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | M - OptEx | $0.00 | +17.5K | 31.6K | +124% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | M - OptEx | $0.00 | +11.3K | 20.1K | +127% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | J - Other | $0.00 | -3,121 | 17.7K | -15% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | F - Tax | $63.11 | -3,610 | 12.4K | -23% | -$227.8K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | F - Tax | $53.79 | -1,965 | 11.3K | -15% | -$105.7K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | M - OptEx | $0.00 | +9,143 | 15.2K | +151% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | J - Other | $0.00 | -2,789 | 7,763 | -26% | $0 |
| D | 2023-12-05 | 2023-12-02 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | M - OptEx | $0.00 | +616 | 7,200 | +9% | $0 |
| D | 2023-12-05 | 2023-12-02 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | F - Tax | $50.10 | -274 | 6,926 | -4% | -$13.7K |
| 2023-08-07 | 2023-08-03 | BMY | Bristol Myers Squibb | Plenge Robert M | EVP, Chief Research Off | S - Sale | $61.14 | -732 | 6,584 | -10% | -$44.8K |
Purchase Sale Sale after option exercise All abbreviations